Chronic obstructive pulmonary disease is associated with worse outcomes in ischemic colitis: a nationwide retrospective study.


Journal

International journal of colorectal disease
ISSN: 1432-1262
Titre abrégé: Int J Colorectal Dis
Pays: Germany
ID NLM: 8607899

Informations de publication

Date de publication:
Nov 2021
Historique:
accepted: 19 04 2021
pubmed: 15 5 2021
medline: 14 10 2021
entrez: 14 5 2021
Statut: ppublish

Résumé

Ischemic colitis (IC) occurs when the blood supply of the large intestine becomes compromised. Several cardiovascular conditions, such as coronary artery disease, congestive heart failure, and atrial fibrillation, are well-established risk factors for the development of IC. The effects of pulmonary conditions, namely chronic obstructive pulmonary disease (COPD), on IC have not been well studied. Our aim was to elucidate if the presence of COPD worsened outcomes in patients with IC. Retrospective analysis of patients hospitalized with IC in 2016 was evaluated using the National Inpatient Sample database. Baseline demographic data, length of hospital stay (LOS), total hospital cost/charge, rates of colectomy, and in-hospital mortality were extracted from the database. Categorical variables were compared using the chi-square test and continuous variables were compared using the t-test. A total of 25,035 patients with IC were identified while 4482 of these patients also had COPD. We found that IC patients with COPD had a longer LOS (5.8 days vs 4.4 days; P<0.01), higher total hospital charge ($56,682 vs $42,365; P<0.01), higher total hospital cost ($13,603 vs $10,238; P<0.01), higher mortality rate (6.5% vs 3.1%; P<0.01), and higher colectomy rate (5.1% vs 3.7%; P<0.01). The presence of COPD portends poor outcomes in patients with IC. This was evidenced by increased risk of death and increased risk of undergoing colectomy. Given these findings, patients with COPD warrant closer observation. We advocate that COPD be considered as part of the risk assessment of patients with acute IC who need surgical intervention.

Sections du résumé

BACKGROUND BACKGROUND
Ischemic colitis (IC) occurs when the blood supply of the large intestine becomes compromised. Several cardiovascular conditions, such as coronary artery disease, congestive heart failure, and atrial fibrillation, are well-established risk factors for the development of IC. The effects of pulmonary conditions, namely chronic obstructive pulmonary disease (COPD), on IC have not been well studied.
AIMS OBJECTIVE
Our aim was to elucidate if the presence of COPD worsened outcomes in patients with IC.
METHODS METHODS
Retrospective analysis of patients hospitalized with IC in 2016 was evaluated using the National Inpatient Sample database. Baseline demographic data, length of hospital stay (LOS), total hospital cost/charge, rates of colectomy, and in-hospital mortality were extracted from the database. Categorical variables were compared using the chi-square test and continuous variables were compared using the t-test.
RESULTS RESULTS
A total of 25,035 patients with IC were identified while 4482 of these patients also had COPD. We found that IC patients with COPD had a longer LOS (5.8 days vs 4.4 days; P<0.01), higher total hospital charge ($56,682 vs $42,365; P<0.01), higher total hospital cost ($13,603 vs $10,238; P<0.01), higher mortality rate (6.5% vs 3.1%; P<0.01), and higher colectomy rate (5.1% vs 3.7%; P<0.01).
CONCLUSIONS CONCLUSIONS
The presence of COPD portends poor outcomes in patients with IC. This was evidenced by increased risk of death and increased risk of undergoing colectomy. Given these findings, patients with COPD warrant closer observation. We advocate that COPD be considered as part of the risk assessment of patients with acute IC who need surgical intervention.

Identifiants

pubmed: 33987734
doi: 10.1007/s00384-021-03935-5
pii: 10.1007/s00384-021-03935-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2455-2461

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Brandt LJ (2015) Feuerstadt P, Longstreth GF, Boley SJ; American College of Gastroenterology. ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI). Am J Gastroenterol 110:18–45
doi: 10.1038/ajg.2014.395
Uchida T, Matsushima M, Orihashi Y, Dekiden-Monma M, Mizukami H, Nakahara F, Nakamura J, Fujisawa M, Koike J, Suzuki T, Mine T (2018) A case-control study on the risk factors for ischemic colitis. Tokai J Exp Clin Med 43:111–116
pubmed: 30191546
Brandt LJ, Feuerstadt P, Blaszka MC (2010) Anatomic patterns, patient characteristics, and clinical outcomes in ischemic colitis: a study of 313 cases supported by histology. Am J Gastroenterol 105:2245–2253
doi: 10.1038/ajg.2010.217
Moszkowicz D, Mariani A, Trésallet C, Menegaux F (2013) Ischemic colitis: the ABCs of diagnosis and surgical management. J Visc Surg 150:19–28
doi: 10.1016/j.jviscsurg.2013.01.002
Sherid M, Samo S, Sulaiman S, Husein H, Sethuraman SN, Vainder JA (2014) Is CT angiogram of the abdominal vessels needed following the diagnosis of ischemic colitis? A multicenter community study ISRN Gastroenterol 2014:756926
pubmed: 25089208
Higgins PD, Davis KJ, Laine L (2004) Systematic review: the epidemiology of ischaemic colitis. Aliment Pharmacol Ther 19:729–738
doi: 10.1111/j.1365-2036.2004.01903.x
Yadav S, Dave M, Edakkanambeth Varayil J, Harmsen WS, Tremaine WJ, Zinsmeister AR, Sweetser SR, Melton LJ III, Sandborn WJ, Loftus EV Jr (2015) A population-based study of incidence, risk factors, clinical spectrum, and outcomes of ischemic colitis. Clin Gastroenterol Hepatol 13:731–e41
doi: 10.1016/j.cgh.2014.07.061
Tseng J, Loper B, Jain M, Lewis AV, Margulies DR, Alban RF (2017) Predictive factors of mortality after colectomy in ischemic colitis: an ACS-NSQIP database study. Trauma Surg Acute Care Open 2:e000126
doi: 10.1136/tsaco-2017-000126
Trotter JM, Hunt L, Peter MB (2016) Ischaemic colitis. BMJ. 355:i6600
doi: 10.1136/bmj.i6600
Sherid M, Sifuentes H, Samo S, Sulaiman S, Husein H, Tupper R, Spurr C, Vainder J, Sridhar S (2014) Risk factors of recurrent ischemic colitis: a multicenter retrospective study. Korean J Gastroenterol 63:283–291
doi: 10.4166/kjg.2014.63.5.283
Sherid M, Sifuentes H, Samo S, Sulaiman S, Husein H, Tupper R, Sethuraman SN, Spurr C, Vainder JA, Sridhar S (2014) Ischemic colitis: a forgotten entity. Results of a retrospective study in 118 patients. J Dig Dis 15:606–613
doi: 10.1111/1751-2980.12182
Paterno F, McGillicuddy EA, Schuster KM, Longo WE (2010) Ischemic colitis: risk factors for eventual surgery. Am J Surg 200:646–650
doi: 10.1016/j.amjsurg.2010.07.005
Reissfelder C, Sweiti H, Antolovic D, Rahbari NN, Hofer S, Büchler MW, Weitz J, Koch M (2011) Ischemic colitis: who will survive? Surgery. 149:585–592
doi: 10.1016/j.surg.2010.11.008
Longstreth GF, Yao JF (2009) Epidemiology, clinical features, high-risk factors, and outcome of acute large bowel ischemia. Clin Gastroenterol Hepatol 7:1075–1023
doi: 10.1016/j.cgh.2009.05.026
Longstreth GF, Yao JF (2010) Diseases and drugs that increase risk of acute large bowel ischemia. Clin Gastroenterol Hepatol 8:49–54
doi: 10.1016/j.cgh.2009.09.006
Cubiella Fernández J, Núñez Calvo L, González Vázquez E, García García MJ, Alves Pérez MT, Martínez Silva I, Fernández Seara J (2010) Risk factors associated with the development of ischemic colitis. World J Gastroenterol 16:4564–4569
doi: 10.3748/wjg.v16.i36.4564
Huerta C, Rivero E, Montoro MA, García-Rodriguez LA (2011) Risk factors for intestinal ischaemia among patients registered in a UK primary care database: a nested case-control study. Aliment Pharmacol Ther 33:969–978
doi: 10.1111/j.1365-2036.2011.04614.x
Sherid M, Samo S, Sulaiman S, Husein H, Sethuraman SN, Thiruvaiyaru D, Spurr C, Sifuentes H, Sridhar S (2016) Comparison of ischemic colitis in the young and the elderly. WMJ. 115:196–202
pubmed: 29099157
Castleberry AW, Turley RS, Hanna JM, Hopkins TJ, Barbas AS, Worni M, Mantyh CR, Migaly J (2013) A 10-year longitudinal analysis of surgical management for acute ischemic colitis. J Gastrointest Surg 17:784–792
doi: 10.1007/s11605-012-2117-x
Flobert C, Cellier C, Berger A, Ngo A, Cuillerier E, Landi B, Marteau P, Cugnenc PH, Barbier JP (2000) Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol 95:195–198
doi: 10.1111/j.1572-0241.2000.01644.x
Theodoropoulou A, Koutroubakis IE (2008) Ischemic colitis: clinical practice in diagnosis and treatment. World J Gastroenterol 14:7302–7308
doi: 10.3748/wjg.14.7302
Arif R, Farag M, Zaradzki M, Reissfelder C, Pianka F, Bruckner T, Kremer J, Franz M, Ruhparwar A, Szabo G, Beller CJ, Karck M, Kallenbach K, Weymann A (2016) Ischemic colitis after cardiac surgery: can we foresee the threat? PLoS One 11:e0167601
doi: 10.1371/journal.pone.0167601
HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP) 2012 Agency for Healthcare Research and Quality, Rockville, MD
Kermani R, Coury JJ Jr, Dao H et al (2013) A practical mortality risk score for emergent colectomy. Dis Colon Rectum 56:467–474
doi: 10.1097/DCR.0b013e31827d0f93
Kimura T, Shinji A, Horiuchi A, Tanaka N, Nagaya T, Shigeno T, Nakamura N, Komatsu M, Umemura T, Arakura N, Matsumoto A, Tanaka E (2012) Clinical characteristics of young-onset ischemic colitis. Dig Dis Sci 57:1652–1659
doi: 10.1007/s10620-012-2088-5
Corlateanu A, Covantev S, Mathioudakis AG, Botnaru V, Siafakas N (2016) Prevalence and burden of comorbidities in chronic obstructive pulmonary disease. Respir Investig 54:387–396
doi: 10.1016/j.resinv.2016.07.001

Auteurs

Dustin J Uhlenhopp (DJ)

Department of Internal Medicine, MercyOne Des Moines Medical Center, 1111 6th Avenue, Des Moines, IA, 50314, USA. DUhlenhopp@mercydesmoines.org.

Eric Then (E)

Division of Gastroenterology and Hepatology, The Brooklyn Hospital Center - Clinical Affiliate of The Mount Sinai Hospital, Brooklyn, NY, USA.

Mohamed Barakat (M)

Division of Gastroenterology and Hepatology, The Brooklyn Hospital Center - Clinical Affiliate of The Mount Sinai Hospital, Brooklyn, NY, USA.

Febin John (F)

Division of Gastroenterology and Hepatology, The Brooklyn Hospital Center - Clinical Affiliate of The Mount Sinai Hospital, Brooklyn, NY, USA.

Vijay Gayam (V)

Department of Internal Medicine, Interfaith Medical Center, Brooklyn, NY, USA.

Tagore Sunkara (T)

Department of Gastroenterology and Hepatology, MercyOne Des Moines Medical Center, Des Moines, IA, USA.

Vinaya Gaduputi (V)

Department of Gastroenterology and Hepatology, MercyOne Des Moines Medical Center, Des Moines, IA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH